Trademark Overview
On Thursday, June 2, 2016, a trademark application was filed for GENENET with the United States Patent and Trademark Office. The USPTO has given the GENENET trademark a serial number of 87057888. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2017. This trademark is owned by Cellecta, Inc. The GENENET trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Assays for research purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific use; Diagnostic reagents for scientific or research use; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology
Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Reagents for medical use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes
Biological research; Biomedical research services; DNA analysis services for scientific research purposes; Laboratory research services relating to pharmaceuticals; Laboratory research in the field of genetics; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Research and development of new products; Research on the subject of pharmaceuticals; Scientific laboratory services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development and consultation ...
Health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing for diagnostic or treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals